Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Takayoshi Yoshikawa"'
Autor:
Naotake Kobayashi, Norihito Sato, Yuko Fujimura, Tsuyoshi Kihara, Katsuji Sugita, Kouji Takahashi, Katsumi Koike, Tamio Sugawara, Yukio Tada, Hiroshi Nakai, Takayoshi Yoshikawa
Publikováno v:
ACS Omega, Vol 3, Iss 10, Pp 13647-13666 (2018)
Externí odkaz:
https://doaj.org/article/d165d037b7464779bcf5a8df0d389a63
Autor:
Naotake Kobayashi, Norihito Sato, Yuko Fujimura, Tsuyoshi Kihara, Katsuji Sugita, Kouji Takahashi, Katsumi Koike, Tamio Sugawara, Yukio Tada, Hiroshi Nakai, Takayoshi Yoshikawa
Publikováno v:
ACS Omega, Vol 4, Iss 4, Pp 6977-6978 (2019)
Externí odkaz:
https://doaj.org/article/fdb4daf687f24bdebc282ea868c82a00
Autor:
Norihito Sato, Tamio Sugawara, Tsuyoshi Kihara, Katsumi Koike, Takayoshi Yoshikawa, Naotake Kobayashi, Katsuji Sugita, Yukio Tada
Publikováno v:
Chemical and Pharmaceutical Bulletin. 69:314-324
We explored orally effective thyrotropin-releasing hormone (TRH) mimetics, which show high central nervous system effects in structure-activity relationship studies based on in vivo antagonistic activity on reserpine-induced hypothermia (anti-hypothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa00aa382cc9f9171b9a5d969fdab8ef
https://doi.org/10.1248/cpb.c20-00454
https://doi.org/10.1248/cpb.c20-00454
Autor:
Naotake, Kobayashi, Norihito, Sato, Katsuji, Sugita, Tsuyoshi, Kihara, Katsumi, Koike, Tamio, Sugawara, Yukio, Tada, Takayoshi, Yoshikawa
Publikováno v:
Chemicalpharmaceutical bulletin. 69(4)
We explored orally effective thyrotropin-releasing hormone (TRH) mimetics, which show high central nervous system effects in structure-activity relationship studies based on in vivo antagonistic activity on reserpine-induced hypothermia (anti-hypothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27807454b6f03b797a0764f4082b89f8
https://pubmed.ncbi.nlm.nih.gov/33790077
https://pubmed.ncbi.nlm.nih.gov/33790077
Autor:
Takayoshi Yoshikawa, Katsumi Koike, Yuko Fujimura, Tsuyoshi Kihara, Yukio Tada, Kouji Takahashi, Hiroshi Nakai, Katsuji Sugita, Tamio Sugawara, Norihito Sato, Naotake Kobayashi
Publikováno v:
ACS Omega, Vol 3, Iss 10, Pp 13647-13666 (2018)
ACS Omega
ACS Omega
We have explored orally effective thyrotropin-releasing hormone (TRH) mimetics, showing oral bioavailability and brain penetration by structure–activity relationship (SAR) study on the basis of in vivo antagonistic activity on reserpine-induced hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4628309af1aa444d7a8e91e47d82887
https://doaj.org/article/d165d037b7464779bcf5a8df0d389a63
https://doaj.org/article/d165d037b7464779bcf5a8df0d389a63
Autor:
Yukio Tada, Norihito Sato, Takayoshi Yoshikawa, Naotake Kobayashi, Kouji Takahashi, Katsuji Sugita, Tamio Sugawara
Publikováno v:
Journal of Peptide Science. 25
We discovered the orally active thyrotropin-releasing hormone (TRH) mimetic: (4S,5S)-5-methyl-N-{(2S)-1-[(2R)-2-methylpyrrolidin-1-yl]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl}-2-oxo-1,3-oxazolidine-4-carboxamide 1 (rovatirelin). The central nervous sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8ec4791eb1f7aff9b6651dd5455c36
https://doi.org/10.1002/psc.3228
https://doi.org/10.1002/psc.3228
Autor:
Naotake Kobayashi, Norihito Sato, Yuko Fujimura, Tsuyoshi Kihara, Katsuji Sugita, Kouji Takahashi, Katsumi Koike, Tamio Sugawara, Yukio Tada, Hiroshi Nakai, Takayoshi Yoshikawa
Publikováno v:
ACS Omega, Vol 4, Iss 4, Pp 6977-6978 (2019)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7cf707f348f6fc10e3aa9e06b2294b9
https://doi.org/10.1021/acsomega.9b00827
https://doi.org/10.1021/acsomega.9b00827
Autor:
Shingo Ishii, Masaki Sanekata, Yasuyuki Ariyasu, Takayoshi Yoshikawa, Yumiko Itoh, Jingoro Shimada, Takuji Komeda
Publikováno v:
Journal of Infection and Chemotherapy. 21:194-201
Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for manufacturing and marketing in Japan in January 2010. In October 2010, an additional indication for pediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0338c23f553ce8497262ba27a4660018
https://doi.org/10.1016/j.jiac.2014.11.009
https://doi.org/10.1016/j.jiac.2014.11.009
Autor:
Takuji, Komeda, Shingo, Ishii, Yumiko, Itoh, Yasuyuki, Ariyasu, Masaki, Sanekata, Takayoshi, Yoshikawa, Jingoro, Shimada
Publikováno v:
Journal of Infection and Chemotherapy. 20:689-695
Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for manufacturing and marketing in Japan in January 2010. We conducted a drug use investigation of peramivir from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0acb14c2a404d599759940392e16fdee
https://doi.org/10.1016/j.jiac.2014.07.006
https://doi.org/10.1016/j.jiac.2014.07.006
Publikováno v:
Drug Delivery System. 23:460-466
経肺投与は，さまざまな肺疾患に対してきわめて効率のよい薬物投与が期待されるが，製剤をリポソーム化することによって，さらに魅力的な製剤を設計することができる．リポソーム
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4fb70836c19270b9bfaaa4bf2ee29ea
https://doi.org/10.2745/dds.23.460
https://doi.org/10.2745/dds.23.460